Late filing
elevated
Filing comparison
Petros Pharmaceuticals, Inc. told the SEC it could not file its annual report on time
(the “Company”) is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the year ended December 31, 2025 (the “Form 10-K”), because the Company requires additional time to complete and finalize its financial statements required to be included in the Form 10-K.
Evidence
- Days past due date
- 0
- Routine
- No
- Severity
- elevated
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- (the “Company”) is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the year ended December 31, 2025 (the “Form 10-K”), because the Company requires additional time to complete and finalize its financial statements required to be included in the Form 10-K.
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.